Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ichiei Narita

Showing results (1-10 of 659) with videos related to

Pageof 66
Sort By:
Nihon Jinzo Gakkai Shi|January 9, 2019
[Drug-induced kidney injury due to antibiotic agents]Ichiei Narita
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 24, 2015
[Kidney Diseases and Metabolic Disorders--Basics and Applications Required for General Physicians]Ichiei Narita
Kidney International Reports|September 21, 2020
Estimating Growth Rate by a Single Measurement of Kidney Volume in ADPKDIchiei Narita
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 27, 2004
[Gene polymorphisms of renin-angiotensin system in patients with kidney diseases]Ichiei Narita, Fumitake Gejyo
Journal of Bone and Mineral Metabolism|June 27, 2022
Impact of adherence to CKD-MBD guidelines on mortality among Japanese dialysis patients: an ecological studyMinako Wakasugi, Ichiei Narita
Clinical and Experimental Nephrology|October 8, 2022
Prefecture-specific prevalence of overweight/obesity is associated with regional variation in the incidence of treated ESKD in JapanMinako Wakasugi, Ichiei Narita
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 9, 2006
[Encephalopathy of unknown etiology with suspected involvement of Pleurocybella porrigens (Pers.:Fr.) Sing. 2. Pleurocybella porrigens-encephalopathy clustering among patients with kidney failure]Fumitake Gejo, Ichiei Narita
Clinical and Experimental Nephrology|April 12, 2008
Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathyIchiei Narita, Fumitake Gejyo
Nihon Jinzo Gakkai Shi|March 7, 2013
[Nephritis and nephrotic syndrome]Yoshikatsu Kaneko, Ichiei Narita
Nephrology (Carlton, Vic.)|March 12, 2004
Current clinical and pathogenetic understanding of beta2-m amyloidosis in long-term haemodialysis patientsFumitake Gejyo, Ichiei Narita
Pageof 66

Showing results (1-10 of 659) with videos related to

Sort By:
Pageof 66
Nihon Jinzo Gakkai Shi|January 9, 2019
[Drug-induced kidney injury due to antibiotic agents]Ichiei Narita
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 24, 2015
[Kidney Diseases and Metabolic Disorders--Basics and Applications Required for General Physicians]Ichiei Narita
Kidney International Reports|September 21, 2020
Estimating Growth Rate by a Single Measurement of Kidney Volume in ADPKDIchiei Narita
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 27, 2004
[Gene polymorphisms of renin-angiotensin system in patients with kidney diseases]Ichiei Narita, Fumitake Gejyo
Journal of Bone and Mineral Metabolism|June 27, 2022
Impact of adherence to CKD-MBD guidelines on mortality among Japanese dialysis patients: an ecological studyMinako Wakasugi, Ichiei Narita
Clinical and Experimental Nephrology|October 8, 2022
Prefecture-specific prevalence of overweight/obesity is associated with regional variation in the incidence of treated ESKD in JapanMinako Wakasugi, Ichiei Narita
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 9, 2006
[Encephalopathy of unknown etiology with suspected involvement of Pleurocybella porrigens (Pers.:Fr.) Sing. 2. Pleurocybella porrigens-encephalopathy clustering among patients with kidney failure]Fumitake Gejo, Ichiei Narita
Clinical and Experimental Nephrology|April 12, 2008
Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathyIchiei Narita, Fumitake Gejyo
Nihon Jinzo Gakkai Shi|March 7, 2013
[Nephritis and nephrotic syndrome]Yoshikatsu Kaneko, Ichiei Narita
Nephrology (Carlton, Vic.)|March 12, 2004
Current clinical and pathogenetic understanding of beta2-m amyloidosis in long-term haemodialysis patientsFumitake Gejyo, Ichiei Narita
Pageof 66